{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:44:35Z","timestamp":1773006275077,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T00:00:00Z","timestamp":1488931200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s15010-017-1004-5","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T07:50:00Z","timestamp":1488959400000},"page":"335-339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates"],"prefix":"10.1007","volume":"45","author":[{"given":"B. M.","family":"Knoll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Nog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dhand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,8]]},"reference":[{"key":"1004_CR1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","volume":"27","author":"N Singh","year":"1998","unstructured":"Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis. 1998;27:1266\u201377.","journal-title":"Clin Infect Dis"},{"key":"1004_CR2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1600-6143.2004.00545.x","volume":"4","author":"MM Klote","year":"2004","unstructured":"Klote MM, Agodoa LY, Abbott K. Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998\u20132000. Am J Transplant. 2004;4:1523\u20138.","journal-title":"Am J Transplant"},{"key":"1004_CR3","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","volume":"48","author":"J Torre-Cisneros","year":"2009","unstructured":"Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis. 2009;48:1657\u201365.","journal-title":"Clin Infect Dis"},{"key":"1004_CR4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ajt.12100","volume":"13","author":"AK Subramanian","year":"2013","unstructured":"Subramanian AK, Morris MI, AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant. 2013;13:68\u201376.","journal-title":"Am J Transplant"},{"key":"1004_CR5","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.transproceed.2012.07.035","volume":"44","author":"RS Stucchi","year":"2012","unstructured":"Stucchi RS, Boin IF, Angerami RN, Zanaga L, Ataide EC, Udo EY. Is isoniazid safe for liver transplant candidates with latent tuberculosis? Transplant Proc. 2012;44:2406\u201310.","journal-title":"Transplant Proc"},{"key":"1004_CR6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/tid.12436","volume":"17","author":"SA Grim","year":"2015","unstructured":"Grim SA, Layden JE, Roth P, et al. Latent tuberculosis in kidney and liver transplant patients: a review of treatment practices and outcomes. Transpl Infect Dis. 2015;17:768\u201377.","journal-title":"Transpl Infect Dis"},{"key":"1004_CR7","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1111\/ajt.12470","volume":"13","author":"AS Lemos de","year":"2013","unstructured":"de Lemos AS, Vieira MA, Halpern M, et al. Results of implementation of preventive recommendations for tuberculosis after renal transplantation in an endemic area. Am J Transplant. 2013;13:3230\u20135.","journal-title":"Am J Transplant"},{"key":"1004_CR8","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.transproceed.2006.06.010","volume":"38","author":"R Naqvi","year":"2006","unstructured":"Naqvi R, Akhtar S, Noor H, et al. Efficacy of isoniazid prophylaxis in renal allograft recipients. Transplant Proc. 2006;38:2057\u20138.","journal-title":"Transplant Proc"},{"key":"1004_CR9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/TP.0000000000000133","volume":"98","author":"A Sidhu","year":"2014","unstructured":"Sidhu A, Verma G, Humar A, Kumar D. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Transplantation. 2014;98:671\u20135.","journal-title":"Transplantation"},{"key":"1004_CR10","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/lt.23480","volume":"18","author":"E Fabrega","year":"2012","unstructured":"Fabrega E, Sampedro B, Cabezas J, et al. Chemoprophylaxis with isoniazid in liver transplant recipients. Liver Transplant. 2012;18:1110\u20137.","journal-title":"Liver Transplant"},{"key":"1004_CR11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/lt.22203","volume":"17","author":"SM Jafri","year":"2011","unstructured":"Jafri SM, Singal AG, Kaul D, Fontana RJ. Detection and management of latent tuberculosis in liver transplant patients. Liver Transplant. 2011;17:306\u201314.","journal-title":"Liver Transplant"},{"key":"1004_CR12","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/01.tp.0000266578.45634.4f","volume":"83","author":"AW Jahng","year":"2007","unstructured":"Jahng AW, Tran T, Bui L, Joyner JL. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period. Transplantation. 2007;83:1557\u201362.","journal-title":"Transplantation"},{"key":"1004_CR13","first-page":"364","volume":"63","author":"LK Schluger","year":"1996","unstructured":"Schluger LK, Sheiner PA, Jonas M, et al. Isoniazid hepatotoxicity after orthotopic liver transplantation. Mt Sinai J Med. 1996;63:364\u20139.","journal-title":"Mt Sinai J Med"},{"key":"1004_CR14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/lt.21709","volume":"15","author":"JE Holty","year":"2009","unstructured":"Holty JE, Gould MK, Meinke L, Keeffe EB, Ruoss SJ. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transplant. 2009;15:894\u2013906.","journal-title":"Liver Transplant"},{"key":"1004_CR15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","volume":"174","author":"JJ Saukkonen","year":"2006","unstructured":"Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:935\u201352.","journal-title":"Am J Respir Crit Care Med"},{"key":"1004_CR16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5588\/ijtld.14.0829","volume":"19","author":"EE Bliven-Sizemore","year":"2015","unstructured":"Bliven-Sizemore EE, Sterling TR, Shang N, et al. Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI. Int J Tuberc Lung Dis. 2015;19:1039\u201344.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1004_CR17","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155\u201366.","journal-title":"N Engl J Med"},{"key":"1004_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","volume":"365","author":"NA Martinson","year":"2011","unstructured":"Martinson NA, Barnes GL, Moulton LH, et al. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med. 2011;365:11\u201320.","journal-title":"N Engl J Med"},{"key":"1004_CR19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/TP.0b013e3182a94a2f","volume":"97","author":"DL Castilla De","year":"2014","unstructured":"De Castilla DL, Rakita RM, Spitters CE, et al. Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates. Transplantation. 2014;97:206\u201311.","journal-title":"Transplantation"},{"key":"1004_CR20","first-page":"1650","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011;60:1650\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-017-1004-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-017-1004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-017-1004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T11:00:20Z","timestamp":1496401220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-017-1004-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,8]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1007\/s15010-017-1004-5","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,8]]}}}